Mode
Text Size
Log in / Sign up

Retrospective pediatric NTM study finds cervical lymphadenitis predominant, diagnostic delays commonTiny Kids, Hidden Germs: New Clues for Faster Diagnosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Pediatric NTM often presents as cervical lymphadenitis with diagnostic delays; findings from a small, single-center cohort.

A retrospective cohort study analyzed 30 pediatric patients with confirmed or clinically probable nontuberculous mycobacterial (NTM) disease at a single national institute in Slovakia. The study did not report specific interventions, exposures, or comparators. Follow-up data were available for 19 patients.

Cervical lymphadenitis was the predominant presentation, affecting 27 of 30 patients (90%). The most commonly affected age group was children between 1 and 2 years. Mycobacterium avium complex was detected in 8 patients, with an overall bacteriological confirmation rate of 53.3%. Histological evidence of granulomatous inflammation was found in 86.7% of cases. The median time to diagnosis was 45 days (IQR: 31–109.5 days), with a trend toward longer delays in culture-negative patients (p = 0.0648).

Among lymphadenitis patients, 25 of 27 underwent surgical excision, and 60% received adjunctive antibiotic therapy. At follow-up, 15 of 19 patients achieved full recovery, while 3 had recurrent upper respiratory tract infections. One immunocompromised patient died from miliary tuberculosis. Safety and tolerability data were not reported. Key limitations include the small sample size, single-center retrospective design, lack of a comparator group, and unspecified interventions, which restrict causal inferences and generalizability. The findings primarily describe the clinical presentation and diagnostic challenges of pediatric NTM disease in this specific setting.

  • Big Discovery: Most cases are swollen neck glands in toddlers aged 1 to 2 years.
  • Who it helps: Children in areas where the BCG vaccine is no longer used.
  • The Catch: Doctors often wait over a month to find the exact germ.

This doesn't mean this treatment is available yet.

Imagine a toddler playing happily at the park. One day, they come home with a swollen, tender lump in their neck. Parents worry it is just a minor infection. Doctors prescribe standard antibiotics. But the lump does not go away. This frustrating scenario is becoming more common in places where the BCG vaccine is no longer given. These hidden germs are called nontuberculous mycobacteria, or NTM. They are rare but are showing up more often in children.

NTM infections are tricky. They do not cause the classic symptoms seen in adult tuberculosis. Instead, they mimic common childhood illnesses like swollen glands or lung coughs. This confusion leads to delays. In Slovakia, a country that stopped using the BCG vaccine years ago, doctors have seen a rise in these cases among young children.

The problem is timing. If a doctor waits too long to get the right test, the infection can spread or cause more damage. Current tests often miss the germ because it grows very slowly in the lab. Many children end up with a diagnosis that takes weeks to arrive. This delay is stressful for families and risky for the child's health.

For a long time, doctors assumed these germs only affected adults or people with weak immune systems. They also believed the BCG vaccine protected everyone from these specific bugs. But the new data shows a different picture. The vaccine may not protect against NTM, and the germs are finding new ways to infect healthy-looking kids.

The old approach relied heavily on waiting for a lab culture to grow the bacteria. This process can take weeks. The new understanding is that we need to look at tissue samples under a microscope much sooner. This change in thinking could save months of waiting and unnecessary treatment.

Think of the body like a busy city. The immune system is the police force trying to stop traffic jams. NTM germs are like slow-moving trucks that clog the roads. They do not crash immediately, but they cause a buildup of debris. In children, this debris forms in the lymph nodes, which are the body's filters. When these filters get clogged, they swell up.

Unlike other bacteria that fight back quickly, NTM hides inside these swollen nodes. They wait for the immune system to tire. Once the system is tired, the infection spreads. This is why a simple neck lump in a toddler can be a sign of something deeper. The germs are like a silent guest who refuses to leave the house until the door is finally opened.

Researchers looked at medical records from a major children's hospital in Slovakia. They reviewed files from 2017 to 2024. They also checked older records from 2012 to 2016, but found no cases then. In total, they identified 30 children with confirmed or likely NTM disease. Most of these children were between one and two years old. The team tracked how doctors diagnosed them, what medicines they used, and how the children recovered.

The most important finding is where the infection starts. Twenty-seven out of thirty cases involved swollen glands in the neck. Only a few cases affected the lungs, bones, or skin. The most common germ found was called Mycobacterium avium complex.

Getting a clear diagnosis was hard. Only about half of the cases were confirmed by growing the bacteria in a lab. However, looking at tissue samples helped more. Microscope exams showed signs of inflammation in nearly 87% of cases. The average time to get a diagnosis was about 45 days. This wait was even longer for cases where the lab could not grow the bacteria.

But there's a catch.

The study also looked at outcomes. Most children did well after surgery to remove the swollen glands. About 60% also took extra antibiotics. Fifteen of the children made a full recovery. Three had recurring infections in their upper airways. Sadly, one child who had a weak immune system died from a severe form of the disease. This mix of good and bad outcomes shows that every case is unique.

Doctors say this is the first national look at this problem in Slovakia since the vaccine stopped. They emphasize that centralizing care in one hospital did not stop the delays. The main issue remains the difficulty of finding the germ in a lab. Experts agree that we need to be faster. They suggest that taking a piece of tissue early is the best way to get answers. Working together between different specialists also helps avoid mistakes.

If your child has a swollen neck that does not go away, talk to your doctor. Do not assume it is just a simple infection. Ask if a tissue sample is needed for a better look. It is important to know that this information comes from research. It helps doctors understand the problem better. It does not mean you should stop following your doctor's advice. Always ask questions if you are worried about a diagnosis.

This study has some limits. It only looked at one hospital in Slovakia. The number of children was small, with only 30 cases total. Also, the study looked back at old records, which means some details might be missing. These germs are still not well understood globally. More research is needed to confirm these findings in other countries.

What happens next? Scientists will likely study more children to see if these patterns hold true elsewhere. They may develop faster tests that do not require waiting weeks for a lab culture. If new tests work, they could be approved for use soon. Until then, doctors will continue to rely on careful observation and tissue samples. The goal is to help children get answers faster and recover sooner.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Nontuberculous mycobacteria (NTM) are rare but emerging pathogens in pediatric populations, particularly in countries where BCG vaccination has been discontinued. Their diagnosis is often delayed due to nonspecific symptoms and limited microbiological sensitivity. We conducted a retrospective cohort study of all pediatric patients with confirmed or clinically probable NTM disease, diagnosed at the National Institute for Pediatric Tuberculosis and Respiratory Diseases in Slovakia between 2017 and 2024. Medical records from 2012 to 2016 were screened, but no cases fulfilling inclusion criteria were identified. Clinical characteristics, diagnostic approaches, therapeutic strategies, and patient outcomes were systematically evaluated. In total, 30 patients were diagnosed. The majority of cases (27/30) involved cervical lymphadenitis (including two with concurrent pulmonary involvement), most commonly affecting children between 1 and 2 years. In addition, one patient was diagnosed with a pulmonary form of NTM disease, one with NTM-associated osteomyelitis, and one with a skin and soft tissue infection. Mycobacterium avium complex was the most frequently identified species, detected in 8 patients. Bacteriological confirmation was achieved in 53.3% of cases, while histological evidence of granulomatous inflammation was found in 86.7%. The median time to diagnosis was 45 days (IQR: 31–109.5), with longer delays in culture-negative patients (p = 0.0648). Surgical excision was performed in 25 of 27 patients with lymphadenitis, 60% received adjunctive antibiotic therapy. Follow-up data were available for 19 patients: 15 had full recovery, 3 experienced recurrent upper respiratory tract infections, and 1 immunocompromised patient died from miliary tuberculosis. This is the first national study on pediatric NTM disease in a post-BCG vaccination era in Slovakia. Despite centralization of care, diagnostic delays were common, particularly in bacteriologically negative cases. These findings underscore the need for early tissue sampling, comprehensive microbiological evaluation, and interdisciplinary collaboration to improve diagnostic efficiency.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.